ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
MP20-16 MR/US FUSION GUIDED ULTRA-FOCAL GOLD NANOSHELL DIRECTED LASER ABLATION OF PROSTATE TUMORS: SIDE EFFECTS AND 1-YEAR FUNCTIONAL OUTCOMES: PHASE I/II CLINICAL TRIAL
The Journal of Urology
◽
10.1097/01.ju.0000555524.26386.ea
◽
2019
◽
Vol 201
(Supplement 4)
◽
Author(s):
Ethan Wajswol*
◽
Harry Anastos
◽
Jared Winoker
◽
Alberto Martini
◽
John Sfakianos
◽
...
Keyword(s):
Clinical Trial
◽
Laser Ablation
◽
Side Effects
◽
Phase I
◽
Functional Outcomes
◽
Prostate Tumors
◽
Gold Nanoshell
Download Full-text
Related Documents
Cited By
References
Re: Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial
European Urology
◽
10.1016/j.eururo.2016.08.064
◽
2017
◽
Vol 71
(2)
◽
pp. 301-302
Author(s):
Rafael Sanchez-Salas
Keyword(s):
Prostate Cancer
◽
Clinical Trial
◽
Laser Ablation
◽
Phase I
◽
Phase I Clinical Trial
Download Full-text
PD65-04 MR/US FUSION GUIDED ULTRA-FOCAL GOLD NANOPARTICLE DIRECTED LASER ABLATION OF PROSTATE TUMORS: RESULTS IN THE FIRST 11 PATIENTS (PHASE I/II TRIAL)
The Journal of Urology
◽
10.1016/j.juro.2018.02.2988
◽
2018
◽
Vol 199
(4S)
◽
Cited By ~ 1
Author(s):
Harry Anastos
◽
Jared Winoker
◽
Pratik Shukla
◽
Shivaram Cumarasamy
◽
John Sfakianos
◽
...
Keyword(s):
Laser Ablation
◽
Phase I
◽
Gold Nanoparticle
◽
Prostate Tumors
Download Full-text
Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial
The Journal of Urology
◽
10.1016/j.juro.2015.12.083
◽
2016
◽
Vol 196
(1)
◽
pp. 68-75
◽
Cited By ~ 45
Author(s):
Shyam Natarajan
◽
Steven Raman
◽
Alan M. Priester
◽
James Garritano
◽
Daniel J.A. Margolis
◽
...
Keyword(s):
Prostate Cancer
◽
Clinical Trial
◽
Laser Ablation
◽
Phase I
◽
Phase I Clinical Trial
Download Full-text
Comparing the Success Rate and Side Effects of Endovenous Laser Ablation and Radiofrequency Ablation to Treat Varicose Veins in the Lower Limbs: A Randomized Clinical Trial
Journal of lasers in medical sciences
◽
10.34172/jlms.2020.s7
◽
2020
◽
Vol 11
(Suppl 1)
◽
pp. S43-S48
Author(s):
Arash Mohammadi Tofigh; Hamed
◽
Javad Zebarjadi
Keyword(s):
Clinical Trial
◽
Radiofrequency Ablation
◽
Laser Ablation
◽
Side Effects
◽
Success Rate
◽
Randomized Clinical Trial
◽
Varicose Veins
◽
Lower Limbs
◽
Endovenous Laser Ablation
Download Full-text
153: Successful Gold Nanoshell Assisted Laser Ablation of Prostate Carcinoma in Vitro
The Journal of Urology
◽
10.1016/s0022-5347(18)30418-x
◽
2007
◽
Vol 177
(4S)
◽
pp. 52-52
Author(s):
Joshua M. Stem
◽
Jer-Tsang Hsieh
◽
Sangtae Park
◽
Yair Lotan
◽
Jeffrey A. Cadeddu
Keyword(s):
Laser Ablation
◽
Prostate Carcinoma
◽
Gold Nanoshell
Download Full-text
Phase I Clinical Trial of a Genetically Modified and Oncolytic Vaccinia Virus GL-ONC1 in patients with peritoneal carcinomatosis
Zeitschrift für Gastroenterologie
◽
10.1055/s-0032-1324086
◽
2012
◽
Vol 50
(08)
◽
Author(s):
UM Lauer
◽
M Zimmermann
◽
U Koppenhöfer
◽
M Bitzer
◽
NP Malek
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Vaccinia Virus
◽
Peritoneal Carcinomatosis
◽
Genetically Modified
◽
Phase I Clinical Trial
Download Full-text
SAFETY OF A NEW CUBAN PNEUMOCOCCAL CONJUGATE VACCINE: A PHASE I CLINICAL TRIAL IN INFANTS 7 MONTH-OLD
10.26226/morressier.5731f0d7d462b8029237fd99
◽
2016
◽
Author(s):
Rinaldo Puga-Gomez
Keyword(s):
Clinical Trial
◽
Phase I
◽
Conjugate Vaccine
◽
Pneumococcal Conjugate Vaccine
◽
Phase I Clinical Trial
Download Full-text
Faculty Opinions recommendation of Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1118816.793494158
◽
2014
◽
Author(s):
Thomas Flaig
Keyword(s):
Prostate Cancer
◽
Clinical Trial
◽
Phase I
◽
Abiraterone Acetate
◽
Selective Inhibitor
◽
Phase I Clinical Trial
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Faculty Opinions recommendation of A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718026292.793481389
◽
2013
◽
Author(s):
Steve Plaxe
◽
Kristy Ward
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
◽
Conditionally Replicative Adenovirus
Download Full-text
Faculty Opinions recommendation of GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.726394953.793529283
◽
2017
◽
Author(s):
Lucy Dorrell
Keyword(s):
Clinical Trial
◽
Human Papillomavirus
◽
Phase I
◽
Therapeutic Vaccine
◽
Phase I Clinical Trial
◽
Cervical Cytology
◽
Human Papillomavirus 16
◽
Normal Cervical Cytology
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close